|
|
|
 Safend
Case Studies
|
Baptist Memorial Hospital
Maintaining Data Security and HIPAA Compliance
A CSO cannot open a newspaper or turn on the network news
without reading or hearing about the latest security breach
in a Fortune 500 company. Internet viruses, data tampering and
information theft top the nightmare lists of IT departments
worldwide. However, finding the latest and greatest security
software may be only half of a successful solution to protecting
corporate assets.
Read Case
Study..
ConnectiCare Health Insurance
ConnectiCare Keeps Customers Covered and Their Data Secure
ConnectiCare knows health insurance. As one of the fastest-growing
HMOs in Connecticut, the company provides insurance coverage
to more than 270,000 individuals in their home state, western
Massachusetts, and four counties of New York.
Read Case
Study..
Philadelphia Stock Exchange
An Ounce of Safend’s Protection Keeps Financial Center Secure
It is the oldest securities exchange in the United States
but there is nothing antique about the Philadelphia Stock Exchange’s
approach to information security. Other companies hold their
breath and cross their fingers, hoping only authorized people
gain access to critical data that’s password-protected, and
that security patches and encryption strategies hold back the
flood of malware waiting to attack from the outside. The Exchange,
on the other hand, developed a strategy to “find the problems
before they find you.”
Read Case
Study..
Transkaryotic Therapies, Inc. (TKT) Biopharmaceutical
TKT utilizes Safend solutions, keeping rare diseases in focus &
data security in check
Transkaryotic Therapies, Inc. (TKT) fights a battle against
rare diseases every day. The global biopharmaceutical company
currently markets the drug Replagal™, which is used in the treatment
of Fabry disease. With a market capitalization greater than
$1.1 billion and 400 employees located in Massachusetts, the
UK, Canada, South America, and Sweden, the fight against data
loss is one TKT cannot afford to lose.
Read Case Study..
|
|
